Drugs / PATAS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07223333 | Jan → Jul 2026 overdue | type 2 diabetes mellitus | AdipoPharma LLC | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PATAS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07223333 ↗ |
| Route | Subcutaneous | “single subcutaneous (SC) doses of PATAS in healthy subjects.” NCT07223333 ↗ |